Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7333 p71-75
22 January 2005

This section
Reprint   Photocopy

PDF 310K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

71 Society complains about delay to Section 60 Order The Royal Pharmaceutical Society has written to the Department of Health to complain about a further delay to the Pharmacy Order under Section 60 of the Health Act 1999 ...more

71 Yellow card data to be published online Patients are now able to report suspected adverse drug reactions direct to the Medicines and Healthcare products Regulatory Agency, which will also publish anonymised data on suspected ADRs online, it was announced this week ...more

71 Pharmacist reviews fail to prevent hospital admissions Medication reviews by pharmacists appear to increase emergency hospital admissions, according to a study published this week ...more

71 Conditions for patients to opt out of new database clarified The Department of Health has clarified the conditions under which patients may opt out of various aspects of the National Programme for IT (NPfIT) electronic database in light of media enquires ...more

72 Huge investment needed to meet WHO health goals The world must immediately and massively increase investment in health programmes to achieve the World Health Organization’s Millennium Development Goals, according to a report presented to UN secretary general Kofi Annan in New Yorkthis week ...more

72 Number misusing drugs falls in Scotland Drug misuse in Scotland is falling, according to research published this week ...more

72 Moderate drinking is shown to be good for women’s minds Moderate drinking does not adversely affect a woman’s cognitive function, according to new research. Moreover, women who drink one alcoholic drink per day have been found to perform better in mental agility tests than those who do not drink ...more

72 Co-operative Group buys out Welsh pharmacy chain Co-operative Group Pharmacy has bought out the Welsh pharmacy group Howard & Palmer Ltd ...more

72 BAPW new website The British Association of Pharmaceutical Wholesalers has launched a new website that will include information about the BAPW, its campaigns and its members ...more

73 People want more information on common ailments People want more information about how to manage common ailments, a survey conducted by Developing Patient Partnerships has shown ...more

73 Diuretics prevent more cardiovascular complications than other monotherapies Diuretics are more effective than other monotherapies in preventing cardiovascular disease complications, an analysis of different treatments has shown ...more

73 Access to patient data would improve illness surveillance Surveillance of winter illnesses and other infections could be greatly enhanced by access to electronic patient data, says a new report ...more

73 BOC defers oxygen proposals Proposals to charge pharmacy contractors rental on oxygen cylinders have been deferred until April ...more

73 Scotland’s pharmacists asked to watch where they stamp Community pharmacists in Scotland are being advised by the Scottish Pharmaceutical General Council to ensure that the pharmacy stamp does not obscure the CHI (community health index) number on prescription forms ...more

74 Delivery devices for asthma are equally effective Devices used to deliver inhaled corticosteroids and bronchodilators can be equally effective, according to the authors of new US evidence-based guidelines. They therefore recommend that other factors be taken into account when selecting a delivery device ...more

74 Fulvestrant adds benefit for women with advanced breast cancer following treatment with aromatase inhibitor Fulvestrant (Faslodex) — an oestrogen receptor antagonist — provides clinical benefit in postmenopausal women with advanced breast cancer that has progressed, despite aromatase inhibitor therapy, results from three clinical trials show ...more

74 Alert issued about damage to Aventis Optipen Pro A warning about a potential problem with Optipen Pro insulin pens, which could result in patients taking extra doses of insulin, has been issued by the Medicines and Healthcare products Regulatory Agency ...more

74 Asda taken to task over analgesic promotions Asda has agreed not to make further volume-based promotional offers on analgesic products following a complaint made to the Medicines and Healthcare products Regulatory Agency ...more

75 Possible new approach to asthma management A novel approach to asthma management could be on the horizon: the use of formoterol/budesonide combination inhalers as both preventer and reliever therapy ...more

75 Once-daily asthma corticosteroid launched Ciclesonide (Alvesco), the first once-daily corticosteroid asthma preventer, has been launched by Altana ...more

75 Short-acting beta2 agonists linked with asthma deaths Use of short-acting beta2 agonists is associated with a modest increase in risk of death in people with asthma, say researchers. However, they warn that the association does not prove that this class of drugs is responsible ...more

75 Clopidogrel and ulcer prevention Patients with a history of aspirin-induced ulcer bleeding fare better if they are treated with aspirin and a proton-pump inhibitor than if they are given clopidogrel (Plavix) ...more

75 Amiodarone no benefit in CHF Amiodarone does not improve survival among patients with mild to moderate congestive heart failure, say researchers ...more

75 Parkinson’s gene mutation A gene mutation has been separately identified by three research groups as the cause of around one in 25 cases of Parkinson’s disease ...more

Back to Top


©The Pharmaceutical Journal